Triglimilife 1mg/500mg/0.2mg Tablet
Marketer
Lakshya Life Sciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Triglimilife 1mg/500mg/0.2mg Tablet
DiabexTrio 1mg/500mg/0.2mg tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes mellitus. This medication helps regulate blood glucose. DiabexTrio 1mg/500mg/0.2mg tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive treatment plan, including dietary adjustments, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes management. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart conditions should inform their physician before commencing treatment. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Triglimilife 1mg/500mg/0.2mg Tablet
Managing Type 2 diabetes
Major Benefits of Triglimilife 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Triglimilife 1mg/500mg/0.2mg Tablet on an empty stomach.
Common Side effects of Triglimilife 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Triglimilife 1mg/500mg/0.2mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Triglimilife 1mg/500mg/0.2mg tablets on an empty stomach.
How Triglimilife 1mg/500mg/0.2mg Tablet works:
One tablet of Triglimilife (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Triglimilife 1mg/500mg/0.2mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Triglimilife 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against the risks before prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Triglimilife 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary data from human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Employing Triglimilife 1mg/500mg/0.2mg tablets in individuals with kidney disease carries a substantial risk and is best avoided. Medical advice is essential. Furthermore, this medication is contraindicated for patients experiencing severe renal impairment.
LiverCAUTION
Patients with liver impairment should use Triglimilife 1mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Triglimilife 1mg/500mg/0.2mg Tablet :
Should you forget a Triglimilife 1mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triglimilife 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
3,018 People bought this recently